Nakanishi, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3642500007
JPY
2,234.00
-2 (-0.09%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Terumo Corp.
HOYA Corp.
Nihon Kohden Corp.
Asahi Intecc Co., Ltd.
JEOL Ltd.
Sumitomo Bakelite Co., Ltd.
Shimadzu Corp.
Sysmex Corp.
Fukuda Denshi Co., Ltd.
Nakanishi, Inc.
Olympus Corp.

Why is Nakanishi, Inc. ?

1
High Management Efficiency with a high ROE of 10.82%
2
Company has very low debt and has enough cash to service the debt requirements
3
The company has declared Negative results for the last 3 consecutive quarters
  • NET PROFIT(HY) At JPY 3,528.08 MM has Grown at -49.13%
  • ROCE(HY) Lowest at 4.19%
  • INTEREST(Q) Highest at JPY 40.04 MM
4
With ROE of 5.82%, it has a very attractive valuation with a 1.54 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -9.30%, its profits have fallen by -47.4%
5
Majority shareholders : FIIs
6
Company is among the highest 1% of companies rated by MarketsMojo across all 4,000 stocks
7
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -9.30% returns in the last 1 year, the stock has also underperformed Japan Nikkei 225 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Nakanishi, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Nakanishi, Inc. for you?

Low Risk, Low Return

Absolute
Risk Adjusted
Volatility
Nakanishi, Inc.
-10.64%
-0.23
30.17%
Japan Nikkei 225
38.59%
1.50
26.58%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
17.58%
EBIT Growth (5y)
10.12%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.21
Sales to Capital Employed (avg)
0.52
Tax Ratio
49.70%
Dividend Payout Ratio
51.30%
Pledged Shares
0
Institutional Holding
0.04%
ROCE (avg)
23.45%
ROE (avg)
10.82%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
26
Industry P/E
Price to Book Value
1.54
EV to EBIT
10.97
EV to EBITDA
7.68
EV to Capital Employed
1.69
EV to Sales
1.97
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
15.41%
ROE (Latest)
5.82%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company
DIVIDEND PAYOUT RATIO(Y)

Highest at 71.02%

RAW MATERIAL COST(Y)

Fallen by -0.58% (YoY

CASH AND EQV(HY)

Highest at JPY 92,762.14 MM

NET SALES(Q)

Highest at JPY 20,647.21 MM

NET PROFIT(Q)

At JPY 3,087.72 MM has Grown at 84.44%

-18What is not working for the Company
NET PROFIT(HY)

At JPY 3,528.08 MM has Grown at -49.13%

ROCE(HY)

Lowest at 4.19%

INTEREST(Q)

Highest at JPY 40.04 MM

Here's what is working for Nakanishi, Inc.

Net Sales
Highest at JPY 20,647.21 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (JPY MM)

Net Profit
At JPY 3,087.72 MM has Grown at 84.44%
over average net sales of the previous four periods of JPY 1,674.11 MM
MOJO Watch
Near term Net Profit trend is positive

Net Profit (JPY MM)

Cash and Eqv
Highest at JPY 92,762.14 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Dividend Payout Ratio
Highest at 71.02%
in the last five years
MOJO Watch
Company is distributing higher proportion of profits generated as dividend

DPR (%)

Raw Material Cost
Fallen by -0.58% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Nakanishi, Inc.

Interest
At JPY 40.04 MM has Grown at 11.9%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Interest
Highest at JPY 40.04 MM
in the last five periods and Increased by 11.9% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)